CapsoVision
its CapsoCam Plus capsule endoscopy device has cleared approval for pediatric use, with the company reporting its first-quarter 2026 financial results as a public company.
- Country
- United States
Commercial
CapsoCam Plus capsule endoscopy
Coverage
| CN | EU | US | |
|---|---|---|---|
| diagnostics-medtech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Ingestible biosensors / smart pills | diagnostics-medtech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.